| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 90361 |
1,2,4,5-四嗪 , 化学式:C2H2N4 |
274 |
WYQ |
2024-12-03 |
| 90362 |
DOTA-Benerotide ;靶向生长抑素受体 |
164 |
wyh |
2024-12-03 |
| 90363 |
1,2,4,5-Tetrazines by Palladium Catalysis(钯催化1,2,4,5-四嗪的合成) |
164 |
WYQ |
2024-12-03 |
| 90364 |
5-苯基-1,2,4-三嗪-3-胺为例,为C9H8N4 |
161 |
WYQ |
2024-12-03 |
| 90365 |
DOTA-PEG-LA-AuNP,DOTA-PEG-硫辛酸修饰纳米金纳米粒子 |
210 |
wyh |
2024-12-03 |
| 90366 |
3,6-二(吡啶-2-基)-1,2,4,5-四嗪(pytz) |
229 |
WYQ |
2024-12-03 |
| 90367 |
HYNIC-PEG11-Tz;联肼尼克酰胺-十一聚乙二醇-四嗪;HYNIC-PEG11-Tetrazine |
226 |
WYQ |
2024-12-03 |
| 90368 |
DOTA-NT肽偶联金纳米粒子 ,DOTA-NT-AuNPs |
170 |
wyh |
2024-12-03 |
| 90369 |
[Zr-89]Zr-DFO-PEG5-Tz;[Zr-89]Zr-DFO-PEG5-Tetrazine |
213 |
WYQ |
2024-12-03 |
| 90370 |
MeTz-NOTA-RGD;甲基四嗪-大环配体-多肽 |
221 |
WYQ |
2024-12-03 |
| 90371 |
DOTA-Tyr(3)-奥曲肽, DOTA-Tyr(3)-Octreotide |
155 |
wyh |
2024-12-03 |
| 90372 |
AgNPs–pytz(3,6-二(吡啶-2-基)-1,2,4,5-四嗪包覆的银纳米粒子) |
169 |
WYQ |
2024-12-03 |
| 90373 |
3,6-di(pyridin-2-yl)-1,2,4,5-s-tetrazine (pytz,3,6-二(吡啶-2-基)-1,4-二氢-1,2,4,5-四嗪) |
177 |
WYQ |
2024-12-03 |
| 90374 |
DOTA-叶酸偶联物,DOTA-Folate |
191 |
wyh |
2024-12-03 |
| 90375 |
CQDs-DOTA-Yb,镱-DOTA螯合物功能化碳量子点 |
185 |
wyh |
2024-12-03 |
| 90376 |
3,6-dihydrazino-s-tetrazine (DHT,3,6-二肼基-s-四嗪) |
184 |
WYQ |
2024-12-03 |
| 90377 |
BCN-PEG-PAMAM ,环丙烷环辛炔-聚乙二醇-聚酰胺 |
227 |
zyl |
2024-12-03 |
| 90378 |
(DNAZTzDMP)2Ni(H2O)2][NO3]2;3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物 |
177 |
WYQ |
2024-12-03 |
| 90379 |
AB1-HLys-DOTA,DOTA偶联阳离子肽 |
183 |
wyh |
2024-12-03 |
| 90380 |
PAMAM-PEG-CKAAKN 树枝状大分子聚酰胺胺-聚乙二醇-CKAAKN多肽 |
187 |
zyl |
2024-12-03 |
| 90381 |
(NH2TzDMP)3Ni][NO3]2;3-氨基-6-(3,5-二甲基吡唑)四嗪配合物 |
139 |
WYQ |
2024-12-03 |
| 90382 |
(DNAZTzDMP)2Co(H2O)2;3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物 |
184 |
WYQ |
2024-12-03 |
| 90383 |
DOTA-1-nal 3-奥曲肽,Ga-DOTA-1-Nal3-octreotide |
136 |
wyh |
2024-12-03 |
| 90384 |
PAMAM-PEG-SP94 树枝状大分子聚酰胺胺-聚乙二醇-SP94多肽 |
165 |
zyl |
2024-12-03 |
| 90385 |
[(DNAZTzDMP)2Co(H2O)2](3-(3,3'-二硝基氮杂环丁烷)-6-(3,5-二甲基吡唑)四嗪配合物) |
191 |
WYQ |
2024-12-03 |
| 90386 |
LLP2A-DOTA-PEG(2000), LLP2A-DOTA-聚乙二醇(2000) |
161 |
wyh |
2024-12-03 |
| 90387 |
[(NH2TzDMP)2Co(H2O)(NO3)][NO3](3-氨基-6-(3,5-二甲基吡唑)四嗪配合物) |
243 |
WYQ |
2024-12-03 |
| 90388 |
3-(3,3'-dinitroazetidine)-6-(3,5-dimethylpyrazole)tetrazine(DNAZTzDMP) |
172 |
WYQ |
2024-12-03 |
| 90389 |
PAMAM-PEG-PTP 树枝状大分子聚酰胺胺-聚乙二醇-PTP多肽 |
169 |
zyl |
2024-12-03 |
| 90390 |
DOTA-SSTR;DOTA修饰生长抑素受体SSTR |
236 |
wyh |
2024-12-03 |
| 90391 |
NOTA-PEG(7)-Tz;大环化合物-七聚乙二醇-四嗪;NOTA-PEG(7)-Tetrazine |
184 |
WYQ |
2024-12-03 |
| 90392 |
PAMAM-PEG-RGDS 树枝状大分子聚酰胺胺-聚乙二醇-RGDS多肽 |
170 |
zyl |
2024-12-03 |
| 90393 |
PEGylated tetrazine;PEG4-Tz;聚乙二醇化四嗪;PEGylated Tz |
212 |
WYQ |
2024-12-03 |
| 90394 |
DOTA-ZOL, DOTA-唑来膦酸 |
150 |
wyh |
2024-12-03 |
| 90395 |
NHS-s-s-tetrazine;N-羟基琥珀酰亚胺-双硫键-四嗪;NHS-s-s-Tz |
203 |
WYQ |
2024-12-03 |
| 90396 |
PAMAM-PEG-c(RGDfC) ,树枝状大分子聚酰胺胺-聚乙二醇-c(RGDfC)多肽 |
230 |
zyl |
2024-12-03 |
| 90397 |
3-amino-6-(3,5-dimethylpyrazole)tetrazine(NH2TzDMP、3-氨基-6-(3,5-二甲基吡唑)四嗪) |
132 |
WYQ |
2024-12-03 |
| 90398 |
DOTA-cyclo(RGDyK) 生物医药探针 |
150 |
zcy |
2024-12-03 |
| 90399 |
Gd-DOTA-氮氧化合物,Gd-DOTA-NOx |
154 |
wyh |
2024-12-03 |
| 90400 |
PAMAM-PEG-Angiopep-2,树枝状大分子聚酰胺胺-聚乙二醇-Angiope-2多肽 |
218 |
zyl |
2024-12-03 |
| 90401 |
cas:250612-06-7 DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 DOTA-RGD探针二聚体 |
144 |
zcy |
2024-12-03 |
| 90402 |
MF-AspDOTA树脂 ,环烯配体AspDOTA功能化三聚氰胺-甲醛(MF)树脂 |
172 |
wyh |
2024-12-03 |
| 90403 |
DOTA-Octreotide 大环配体-奥曲肽 |
166 |
zcy |
2024-12-03 |
| 90404 |
[18F]F-Tz-PEG11-NODA;[18F]F-四嗪-聚(乙二醇)11-1,4,7-三氮杂环壬烷-1,4-二乙酸 |
192 |
WYQ |
2024-12-03 |
| 90405 |
PAMAMG5-SS-PEG2k 聚酰胺胺-双硫键-聚乙二醇 |
252 |
zyl |
2024-12-03 |